A role for connexins in inflammatory disorders of the epidermis

Connexin Cell Communication Channels: Roles in the Immune System and Immunopathology

Volumn , Issue , 2013, Pages 233-253

  Donnelly, Steven ^a   Wright, Catherine S ^a   Van Steensel, Maurice A M ^b   Hodgins, Malcolm B ^a   Martin, Patricia E ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84898904926     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14166     Document Type: Chapter

References (113)

1. Bakirtzis G, Choudhry R, Aasen T, Shore L, Brown K, Bryson S, Forrow S et al. 2003. Targeted epidermal expression of mutant Connexin 26(D66H) mimics true Vohwinkel syndrome and provides a model for the pathogenesis of dominant connexin disorders. Hum Mol Genet 12(14):1737-1744.
2. Bao L, Sachs F, Dahl G. 2004. Connexins are mechanosensitive. Am J Physiol Cell Physiol 287(5):C1389-1395.
3. Blanpain C, Fuchs E. 2009. Epidermal homeostasis: A balancing act of stem cells in the skin. Nat Rev Mol Cell Biol 10(3):207-217.
4. Braet K, Vandamme W, Martin PE, Evans WH, Leybaert L. 2003. Photoliberating inositol-1,4,5-trisphosphate triggers ATP release that is blocked by the connexin mimetic peptide gap 26. Cell Calcium 33(1):37-48.
5. Brandner JM, Houdek P, Husing B, Kaiser C, Moll I. 2004. Connexins 26, 30, and 43:Differences among spontaneous, chronic, and accelerated human wound healing. J Invest Dermatol 122(5):1310-1320.
6. Brobby GW, Muller-Myhsok B, Horstmann RD. 1998. Connexin 26 R143W mutation associated with recessive nonsyndromic sensorineural deafness in Africa. N Engl J Med 338(8):548-550.
7. Buchau AS, Gallo RL. 2007. Innate immunity and antimicrobial defense systems in psoriasis. Clin Dermatol 25(6):616-624.
8. Burnstock G. 2006. Purinergic signalling. Br J Pharmacol 147(Suppl 1):S172-181.
9. Chandross KJ, Spray DC, Cohen RI, Kumar NM, Kremer M, Dermietzel R, Kessler JA. 1996. TNF alpha inhibits Schwann cell proliferation, connexin46 expression, and gap junctional communication. Mol Cell Neurosci 7(6):479-500.
10. Cherian PP, Siller-Jackson AJ, Gu S, Wang X, Bonewald LF, Sprague E, Jiang JX. 2005. Mechanical strain opens connexin 43 hemichannels in osteocytes: A novel mechanism for the release of prostaglandin. Mol Biol Cell 16(7):3100-3106.
11. Choudhry R, Pitts JD, Hodgins MB. 1997. Changing patterns of gap junctional intercellular communication and connexin distribution in mouse epidermis and hair follicles during embryonic development. Dev Dyn 210(4):417-430.
12. Chung E, Cook PW, Parkos CA, Park YK, Pittelkow MR, Coffey RJ. 2005. Amphiregulin causes functional downregulation of adherens junctions in psoriasis. J Invest Dermatol 124(6):1134-1140.
13. Clair C, Combettes L, Pierre F, Sansonetti P, Tran Van Nhieu G. 2008. Extracellular-loop peptide antibodies reveal a predominant hemichannel organization of connexins in polarized intestinal cells. Exp Cell Res 314(6):1250-1265.
14. Cogen AL, Nizet V, Gallo RL. 2008. Skin microbiota: A source of disease or defence? Br J Dermatol 158(3):442-455.
15. Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R, Ward SJ. 2009. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 129(8):1892-1908.
16. Corvalan LA, Araya R, Branes MC, Saez PJ, Kalergis AM, Tobar JA, Theis M, Willecke K, Saez JC. 2007. Injury of skeletal muscle and specific cytokines induce the expression of gap junction channels in mouse dendritic cells. J Cell Physiol 211(3):649-660.
17. D’Adamo P, Guerci VI, Fabretto A, Faletra F, Grasso DL, Ronfani L, Montico M, Morgutti M, Guastalla P, Gasparini P. 2009. Does epidermal thickening explain GJB2 high carrier frequency and heterozygote advantage? Eur J Hum Genet 17(3):284-286.
18. D’Hondt C, Ponsaerts R, De Smedt H, Bultynck G, Himpens B. 2009. Pannexins, distant relatives of the connexin family with specific cellular functions? Bioessays 31(9):953-974.
19. De Vuyst E, Decrock E, De Bock M, Yamasaki H, Naus CC, Evans WH, Leybaert L. 2007. Connexin hemichannels and gap junction channels are differentially influenced by lipopolysaccharide and basic fibroblast growth factor. Mol Biol Cell 18(1):34-46.
20. de Zwart-Storm EA, Hamm H, Stoevesandt J, Steijlen PM, Martin PE, van Geel M, van Steensel MA. 2008a. A novel missense mutation in GJB2 disturbs gap junction protein transport and causes focal palmoplantar keratoderma with deafness. J Med Genet 45(3):161-166.
21. de Zwart-Storm EA, Martin, P.E., and van Steensel. M.A.M. 2009. Gap junction diseases of the skin-Novel insights from new mutations. Expert Rev Dermatol 4:455-468.
22. de Zwart-Storm EA, Rosa RF, Martin PE, Foelster-Holst R, Frank J, Bau AE, Zen PR et al. 2011. Molecular analysis of connexin26 asparagine14 mutations associated with syndromic skin phenotypes. Exp Dermatol 20(5):408-412.
23. de Zwart-Storm EA, van Geel M, van Neer PA, Steijlen PM, Martin PE, van Steensel MA. 2008b. A novel missense mutation in the second extracellular domain of GJB2, p.Ser183Phe, causes a syndrome of focal palmoplantar keratoderma with deafness. Am J Pathol 173(4):1113-1119.
24. Denda M, Inoue K, Fuziwara S, Denda S. 2002. P2X purinergic receptor antagonist accelerates skin barrier repair and prevents epidermal hyperplasia induced by skin barrier disruption. J Invest Dermatol 119(5):1034-1040.
25. Di WL, Rugg EL, Leigh IM, Kelsell DP. 2001. Multiple epidermal connexins are expressed in different keratinocyte subpopulations including connexin 31. J Invest Dermatol 117(4):958-964.
26. Dixon CJ, Bowler WB, Littlewood-Evans A, Dillon JP, Bilbe G, Sharpe GR, Gallagher JA. 1999. Regulation of epidermal homeostasis through P2Y2 receptors. Br J Pharmacol 127(7):1680-1686.
27. Djalilian AR, Kim JY, Saeed HN, Holland EJ, Chan CC. 2010. Histopathology and treatment of corneal disease in keratitis, ichthyosis, and deafness (KID) syndrome. Eye (Lond) 24(4):738-740.
28. Djalilian AR, McGaughey D, Patel S, Seo EY, Yang C, Cheng J, Tomic M, Sinha S, Ishida-Yamamoto A, Segre JA. 2006. Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response. J Clin Invest 116(5):1243-1253.
29. Donnelly S, English, G, Lang S, de Zwart-Storm E, van Steensel MAM, and Martin PE. 2012. Differential susceptibility of Cx26 mutations associated with epidermal dysplasia’s to Peptidoglycan derived from S. aureus and S. epidermidis. Exp Dermatol 8: 592-598.
30. Easton JA, Donnelly S, Kamps MA, Steijlen PM, Martin PE, Tadini G, Janssens R, Happle R, van Geel M, van Steensel MA. 2012. Porokeratotic eccrine nevus may be caused by somatic connexin26 mutations. J Invest Dermatol 132(9): 2181-2191.
31. Ekanayake-Mudiyanselage S, Aschauer H, Schmook FP, Jensen JM, Meingassner JG, Proksch E. 1998. Expression of epidermal keratins and the cornified envelope protein involucrin is influenced by permeability barrier disruption. J Invest Dermatol 111(3):517-523.
32. Esen N, Shuffield D, Syed MM, Kielian T. 2007. Modulation of connexin expression and gap junction communication in astrocytes by the Gram-positive bacterium S. aureus. Glia 55(1):104-117.
33. Eugenin EA, Eckardt D, Theis M, Willecke K, Bennett MV, Saez JC. 2001. Microglia at brain stab wounds express connexin 43 and in vitro form functional gap junctions after treatment with interferon-gamma and tumor necrosis factor-alpha. Proc Natl Acad Sci USA 98(7):4190-4195.
34. Evans WH, De Vuyst E, Leybaert L. 2006. The gap junction cellular internet: Connexin hemichannels enter the signalling limelight. Biochem J 397(1):1-14.
35. Evans WH, Leybaert L. 2007. Mimetic peptides as blockers of connexin channel-facilitated intercellular communication. Cell Commun Adhes 14(6):265-273.
36. Fort AG, Murray, J.W., Dandachi, N., Davidson, M.W., Dermietzel, R., Wolkoff, A.W., Spray, D.C. 2012. In vitro motility of liver connexin vesicles along microtubules utilizes kinesin motors. J Biol Chem 286(26): 22875-22885.
37. Fruscione F, Scarfi S, Ferraris C, Bruzzone S, Benvenuto F, Guida L, Uccelli A et al. 2010. Regulation of human mesenchymal stem cell functions by an autocrine loop involving NAD(+) release and P2Y11-mediated signaling. Stem Cells Dev 20(7): 1183-1198.
38. Garg S, Md Syed M, Kielian T. 2005. Staphylococcus aureus-derived peptidoglycan induces Cx43 expression and functional gap junction intercellular communication in microglia. J Neurochem 95(2):475-483.
39. Garrod D, Chidgey M. 2008. Desmosome structure, composition and function. Biochim Biophys Acta 1778(3):572-587.
40. Gourdie RG, Ghatnekar GS, O’Quinn M, Rhett MJ, Barker RJ, Zhu C, Jourdan J, Hunter AW. 2006. The unstoppable connexin43 carboxyl-terminus: New roles in gap junction organization and wound healing. Ann N Y Acad Sci 1080:49-62.
41. Granstein RD, Ding W, Huang J, Holzer A, Gallo RL, Di Nardo A, Wagner JA. 2005. Augmentation of cutaneous immune responses by ATP gamma S: Purinergic agonists define a novel class of immunologic adjuvants. J Immunol 174(12):7725-7731.
42. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, Bouffard GG et al. 2009. Topographical and temporal diversity of the human skin microbiome. Science 324(5931):1190-1192.
43. Guastalla P, Guerci VI, Fabretto A, Faletra F, Grasso DL, Zocconi E, Stefanidou D et al. 2009. Detection of epidermal thickening in GJB2 carriers with epidermal US. Radiology 251(1):280-286.
44. Guttman JA, Lin AE, Li Y, Bechberger J, Naus CC, Vogl AW, Finlay BB. 2009. Gap junction hemichannels contribute to the generation of diarrhea during infectious enteric disease. Gut 59:218-226.
45. Haghikia A, Ladage K, Hinkerohe D, Vollmar P, Heupel K, Dermietzel R, Faustmann PM. 2008a. Implications of antiinflammatory properties of the anticonvulsant drug levetiracetam in astrocytes. J Neurosci Res 86(8):1781-1788.
46. Haghikia A, Ladage K, Lafenetre P, Hinkerohe D, Smikalla D, Haase CG, Dermietzel R, Faustmann PM. 2008b. Intracellular application of TNF-alpha impairs cell to cell communication via gap junctions in glioma cells. J Neurooncol 86(2):143-152.
47. Hamelmann C, Amedofu GK, Albrecht K, Muntau B, Gelhaus A, Brobby GW, Horstmann RD. 2001. Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana. Hum Mutat 18(1):84-85.
48. Hampton PJ, Ross OK, Reynolds NJ. 2007. Increased nuclear beta-catenin in suprabasal involved psoriatic epidermis. Br J Dermatol 157(6):1168-1177.
49. Haruna K, Suga Y, Oizumi A, Mizuno Y, Endo H, Shimizu T, Hasegawa T, Ikeda S. 2010. Severe form of keratitis-ichthyosis-deafness (KID) syndrome associated with septic complications. J Dermatol 37(7):680-682.
50. Hinkerohe D, Smikalla D, Schoebel A, Haghikia A, Zoidl G, Haase CG, Schlegel U, Faustmann PM. 2010. Dexamethasone prevents LPS-induced microglial activation and astroglial impairment in an experimental bacterial meningitis co-culture model. Brain Res 1329:45-54.
51. Hivnor C, Williams N, Singh F, VanVoorhees A, Dzubow L, Baldwin D, Seykora J. 2004. Gene expression profiling of porokeratosis demonstrates similarities with psoriasis. J Cutan Pathol 31(10):657-664.
52. Holland DB, Bojar RA, Farrar MD, Holland KT. 2009. Differential innate immune responses of a living skin equivalent model colonized by Staphylococcus epidermidis or Staphylococcus aureus. FEMS Microbiol Lett 290(2):149-155.
53. Janecke AR, Hennies HC, Gunther B, Gansl G, Smolle J, Messmer EM, Utermann G, Rittinger O. 2005. GJB2 mutations in keratitis-ichthyosis-deafness syndrome including its fatal form. Am J Med Genet A 133A(2):128-131.
54. Kandyba EE, Hodgins MB, Martin PE. 2008. A murine living skin equivalent amenable to live-cell imaging: Analysis of the roles of connexins in the epidermis. J Invest Dermatol 128(4):1039-1049.
55. Kelly B, Lozano A, Altenberg G, Makishima T. 2008. Connexin 26 mutation in keratitis-ichthyosis- deafness (KID) syndrome in mother and daughter with combined conductive and sensorineural hearing loss. Int J Dermatol 47(5):443-447.
56. Kim BE, Howell MD, Guttman E, Gilleaudeau PM, Cardinale IR, Boguniewicz M, Krueger JG, Leung DY. 2011. TNF-alpha downregulates filaggrin and loricrin through c-Jun N-terminal kinase: Role for TNF-alpha antagonists to improve skin barrier. J Invest Dermatol 131(6):1272-1279.
57. Kirschner N, Poetzl C, von den Driesch P, Wladykowski E, Moll I, Behne MJ, Brandner JM. 2009. Alteration of tight junction proteins is an early event in psoriasis: Putative involvement of proinflammatory cytokines. Am J Pathol 175(3):1095-1106.
58. Kjolbye AL, Haugan K, Hennan JK, Petersen JS. 2007. Pharmacological modulation of gap junction function with the novel compound rotigaptide: A promising new principle for prevention of arrhythmias. Basic Clin Pharmacol Toxicol 101(4):215-230.
59. Koppelhus U, Tranebjaerg L, Esberg G, Ramsing M, Lodahl M, Rendtorff ND, Olesen HV, Sommerlund M. 2011. A novel mutation in the connexin 26 gene (GJB2) in a child with clinical and histological features of keratitis-ichthyosis-deafness (KID) syndrome. Clin Exp Dermatol 36(2):142-148.
60. Kristensen M, Chu CQ, Eedy DJ, Feldmann M, Brennan FM, Breathnach SM. 1993. Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: Epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clin Exp Immunol 94(2):354-362.
61. Kumar H, Kawai T, Akira S. 2009. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 388(4):621-625.
62. Labarthe MP, Bosco D, Saurat JH, Meda P, Salomon D. 1998. Upregulation of connexin 26 between keratinocytes of psoriatic lesions. J Invest Dermatol 111(1):72-76.
63. Lai Y, Cogen AL, Radek KA, Park HJ, Macleod DT, Leichtle A, Ryan AF, Di Nardo A, Gallo RL. 2010. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol 130(9):2211-2221.
64. Lai Y, Gallo RL. 2008. Toll-like receptors in skin infections and inflammatory diseases. Infect Disord Drug Targets 8(3):144-155.
65. Laird DW. 2006. Life cycle of connexins in health and disease. Biochem J 394(Pt 3):527-543.
66. Lee JR, Derosa AM, White TW. 2009. Connexin mutations causing skin disease and deafness increase hemichannel activity and cell death when expressed in Xenopus oocytes. J Invest Dermatol 129(4):870-878.
67. Li Z, Peng Z, Wang Y, Geng S, Ji F. 2008. Decreased expression of E-cadherin and beta-catenin in the lesional skin of patients with active psoriasis. Int J Dermatol 47(2):207-209.
68. Lucke T, Choudhry R, Thom R, Selmer IS, Burden AD, Hodgins MB. 1999. Upregulation of connexin 26 is a feature of keratinocyte differentiation in hyperproliferative epidermis, vaginal epithelium, and buccal epithelium. J Invest Dermatol 112(3):354-361.
69. Maeda S, Nakagawa S, Suga M, Yamashita E, Oshima A, Fujiyoshi Y, Tsukihara T. 2009. Structure of the connexin 26 gap junction channel at 3.5 A resolution. Nature 458(7238):597-602.
70. Man YK, Trolove C, Tattersall D, Thomas AC, Papakonstantinopoulou A, Patel D, Scott C et al. 2007. A deafness-associated mutant human connexin 26 improves the epithelial barrier in vitro. J Membr Biol 218(1-3):29-37.
71. Martin PE, Blundell G, Ahmad S, Errington RJ, Evans WH. 2001. Multiple pathways in the trafficking and assembly of connexin 26, 32 and 43 into gap junction intercellular communication channels. J Cell Sci 114(Pt 21):3845-3855.
72. Martin PE, Wall C, Griffith TM. 2005. Effects of connexin-mimetic peptides on gap junction functionality and connexin expression in cultured vascular cells. Br J Pharmacol 144(5):617-627.
73. Martinez AD, Acuna R, Figueroa V, Maripillan J, Nicholson B. 2009. Gap-junction channels dysfunction in deafness and hearing loss. Antioxid Redox Signal 11(2):309-322.
74. Matsue H, Yao J, Matsue K, Nagasaka A, Sugiyama H, Aoki R, Kitamura M, Shimada S. 2006. Gap junction-mediated intercellular communication between dendritic cells (DCs) is required for effective activation of DCs. J Immunol 176(1):181-190.
75. Mazereeuw-Hautier J, Bitoun E, Chevrant-Breton J, Man SY, Bodemer C, Prins C, Antille C et al. 2007. Keratitis-ichthyosis-deafness syndrome: Disease expression and spectrum of connexin 26 (GJB2) mutations in 14 patients. Br J Dermatol 156(5):1015-1019.
76. Meyer CG, Amedofu GK, Brandner JM, Pohland D, Timmann C, Horstmann RD. 2002. Selection for deafness? Nat Med 8(12):1332-1333.
77. Mizumoto N, Kumamoto T, Robson SC, Sevigny J, Matsue H, Enjyoji K, Takashima A. 2002. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: Modulatory roles in inflammation and immune responsiveness. Nat Med 8(4):358-365.
78. Moniaga CS, Egawa G, Kawasaki H, Hara-Chikuma M, Honda T, Tanizaki H, Nakajima S et al. 2010. Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract. Am J Pathol 176(5):2385-2393.
79. Mori R, Power KT, Wang CM, Martin P, Becker DL. 2006. Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration. J Cell Sci 119(Pt 24):5193-5203.
80. Nyquist GG, Mumm C, Grau R, Crowson AN, Shurman DL, Benedetto P, Allen P et al. 2007. Malignant proliferating pilar tumors arising in KID syndrome: A report of two patients. Am J Med Genet A 143(7):734-741.
81. Oshima A, Tani K, Toloue MM, Hiroaki Y, Smock A, Inukai S, Cone A, Nicholson BJ, Sosinsky GE, Fujiyoshi Y. 2011. Asymmetric configurations and N-terminal rearrangements in connexin26 gap junction channels. J Mol Biol 405(3):724-735.
82. Pillai S, Bikle DD. 1992. Adenosine triphosphate stimulates phosphoinositide metabolism, mobilizes intracellular calcium, and inhibits terminal differentiation of human epidermal keratinocytes. J Clin Invest 90(1):42-51.
83. Pollok S, Pfeiffer AC, Lobmann R, Wright CS, Moll I, Martin PE, Brandner JM. 2011. Connexin 43 mimetic peptide Gap27 reveals potential differences in the role of Cx43 in wound repair between diabetic and non-diabetic cells. J Cell Mol Med 15(4): 861-873.
84. Proksch E, Brandner JM, Jensen JM. 2008. The skin: An indispensable barrier. Exp Dermatol 17(12):1063-1072.
85. Qiu C, Coutinho P, Frank S, Franke S, Law LY, Martin P, Green CR, Becker DL. 2003. Targeting connexin43 expression accelerates the rate of wound repair. Curr Biol 13(19):1697-1703.
86. Retamal MA, Froger N, Palacios-Prado N, Ezan P, Saez PJ, Saez JC, Giaume C. 2007a. Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J Neurosci 27(50):13781-13792.
87. Retamal MA, Schalper KA, Shoji KF, Bennett MV, Saez JC. 2007b. Opening of connexin 43 hemichannels is increased by lowering intracellular redox potential. Proc Natl Acad Sci USA 104(20):8322-8327.
88. Richard G, Rouan F, Willoughby CE, Brown N, Chung P, Ryynanen M, Jabs EW et al. 2002. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis- ichthyosis-deafness syndrome. Am J Hum Genet 70(5):1341-1348.
89. Richardson SK, Gelfand JM. 2008. Update on the natural history and systemic treatment of psoriasis. Adv Dermatol 24:171-196.
90. Robertson J, Lang S, Lambert PA, Martin PE. 2010. Peptidoglycan derived from Staphylococcus epidermidis induces Connexin43 hemichannel activity with consequences on the innate immune response in endothelial cells. Biochem J 432(1):133-143.
91. Romani N, Clausen BE, Stoitzner P. 2010. Langerhans cells and more: Langerin-expressing dendritic cell subsets in the skin. Immunol Rev 234(1):120-141.
92. Romani N, Ebner S, Tripp CH, Flacher V, Koch F, Stoitzner P. 2006. Epidermal Langerhans cells-Changing views on their function in vivo. Immunol Lett 106(2):119-125.
93. Sandilands A, Sutherland C, Irvine AD, McLean WH. 2009. Filaggrin in the frontline: Role in skin barrier function and disease. J Cell Sci 122(Pt 9):1285-1294.
94. Schutz M, Auth T, Gehrt A, Bosen F, Korber I, Strenzke N, Moser T, Willecke K. 2010. The connexin26 S17F mouse mutant represents a model for the human hereditary keratitisichthyosis- deafness syndrome. Hum Mol Genet 20(1):28-39.
95. Shaw RM, Fay AJ, Puthenveedu MA, von Zastrow M, Jan YN, Jan LY. 2007. Microtubule plus-end-tracking proteins target gap junctions directly from the cell interior to adherens junctions. Cell 128(3):547-560.
96. Skinner BA, Greist MC, Norins AL. 1981. The keratitis, ichthyosis, and deafness (KID) syndrome. Arch Dermatol 117(5):285-289.
97. Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao Y, Liao H et al. 2006. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 38(3):337-342.
98. Steffens M, Gopel F, Ngezahayo A, Zeilinger C, Ernst A, Kolb HA. 2008. Regulation of connexons composed of human connexin26 (hCx26) by temperature. Biochim Biophys Acta 1778(5):1206-1212.
99. Tacheau C, Fontaine J, Loy J, Mauviel A, Verrecchia F. 2008a. TGF-beta induces connexin43 gene expression in normal murine mammary gland epithelial cells via activation of p38 and PI3K/AKT signaling pathways. J Cell Physiol 217(3):759-768.
100. Tacheau C, Laboureau J, Mauviel A, Verrecchia F. 2008b. TNF-alpha represses connexin43 expression in HaCat keratinocytes via activation of JNK signaling. J Cell Physiol 216(2):438-444.
101. Tonel G, Conrad C. 2009. Interplay between keratinocytes and immune cells-Recent insights into psoriasis pathogenesis. Int J Biochem Cell Biol 41(5):963-968.
102. Tonon R, D’Andrea P. 2000. Interleukin-1beta increases the functional expression of connexin 43 in articular chondrocytes: Evidence for a Ca2+-dependent mechanism. J Bone Miner Res 15(9):1669-1677.
103. Tran Van Nhieu G, Clair C, Bruzzone R, Mesnil M, Sansonetti P, Combettes L. 2003. Connexin-dependent inter-cellular communication increases invasion and dissemination of Shigella in epithelial cells. Nat Cell Biol 5(8):720-726.
104. Tschachler E. 2007. Psoriasis: The epidermal component. Clin Dermatol 25(6):589-595.
105. van Rijen HV, van Kempen MJ, Postma S, Jongsma HJ. 1998. Tumour necrosis factor alpha alters the expression of connexin43, connexin40, and connexin37 in human umbilical vein endothelial cells. Cytokine 10(4):258-264.
106. van Steensel MA, van Geel M, Nahuys M, Smitt JH, Steijlen PM. 2002. A novel connexin 26 mutation in a patient diagnosed with keratitis-ichthyosis-deafness syndrome. J Invest Dermatol 118(4):724-727.
107. Wagner EF, Schonthaler HB, Guinea-Viniegra J, Tschachler E. 2010. Psoriasis: What we have learned from mouse models. Nat Rev Rheumatol 6(12):704-714.
108. Wang CM, Lincoln J, Cook JE, Becker DL. 2007. Abnormal connexin expression underlies delayed wound healing in diabetic skin. Diabetes 56(11):2809-2817.
109. Wang XP, Schunck M, Kallen KJ, Neumann C, Trautwein C, Rose-John S, Proksch E. 2004. The interleukin-6 cytokine system regulates epidermal permeability barrier homeostasis. J Invest Dermatol 123(1):124-131.
110. Weidinger S, O’Sullivan M, Illig T, Baurecht H, Depner M, Rodriguez E, Ruether A et al. 2008. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol 121(5):1203-1209 e1201.
111. Wright CS, Pollok S, Flint DJ, Brandner JM, Martin PE. 2012. The connexin mimetic peptide Gap27 increases human dermal fibroblast migration in hyperglycemic and hyperinsulinemic conditions in vitro. J Cell Physiol 227(1):77-87.
112. Wright CS, van Steensel MA, Hodgins MB, Martin PE. 2009. Connexin mimetic peptides improve cell migration rates of human epidermal keratinocytes and dermal fibroblasts in vitro. Wound Repair Regen 17(2):240-249.
113. Zimmerli SC, Kerl K, Hadj-Rabia S, Hohl D, Hauser C. 2008. Human epidermal Langerhans cells express the tight junction protein claudin-1 and are present in human genetic claudin-1 deficiency (NISCH syndrome). Exp Dermatol 17(1):20-23.